Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Emerging-Markets Bond · MFS

MFS Emerging Markets Debt Fund A (MEDAX)

Ticker MEDAX · · Holdings as of Jul 31, 2026

Expense ratio
1.07%$107/yr per $10k
5-yr return
+0.1%annualized
1-yr return
+2.3%as of Dec 2024
Net assets
$7.5Ball share classes
Holdings
504

Bottom line

Is MEDAX a good fund? The bottom line

MEDAX is a share class of MFS Emerging Markets Debt Fund, a managed emerging-markets bond mutual fund from MFS.

It charges 1.07% — about $107 a year on every $10,000 invested, more expensive than 63% of emerging-markets bond funds we track.

It returned +2.3% over one year, +0.1% a year over five years, +2.5% a year over ten (as of Dec 31, 2024, per its prospectus).

With $7.5 billion in net assets and 504 holdings, its largest position is MFS Institutional Money Market Portfolio (4.4%) and the top 10 make up 12.6% of the portfolio.

This share class carries a front-end sales charge of up to 4.25%; a no-load class or ETF alternative can avoid it.

What stands out

  • Broadly diversified (504 holdings)

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 4.25%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What MEDAX invests in

The funds investment objective is to seek total return with an emphasis on high current income, but also considering capital appreciation.

MFS (Massachusetts Financial Services Company, the fund's investment adviser) normally invests at least 80% of the funds net assets in debt instruments of issuers that are tied economically to emerging market countries. Emerging markets are countries determined to have emerging market economies based on factors that demonstrate the country's financial and capital markets are in the development phase, including whether a particular country has a low- to middle-income economy according to the International Bank for Reconstruction and Development (the World Bank), the countrys designation by the International Monetary Fund as an emerging market, or the country's inclusion in an emerging market index. Emerging market countries include countries located in Latin America, Asia, Africa, the Middle East, and developing countries of Europe, primarily Eastern Europe. Debt instruments include…

From the fund's prospectus (filed Nov 26, 2025).

MEDAX performance

Fund calendar-year total returns, 2015–2024 2015: −0.8%; 2016: +9.2%; 2017: +9.3%; 2018: −5.2%; 2019: +13.8%; 2020: +7.7%; 2021: −2.7%; 2022: −15.0%; 2023: +10.2%; 2024: +6.8% −1% 2015 +9% 2016 +9% 2017 −5% 2018 +14% 2019 +8% 2020 −3% 2021 −15% 2022 +10% 2023 +7% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MEDAX+2.3%+0.1%+2.5%
Emerging-Markets Bond median+14.5%+1.6%+4.0%

Source: Fund prospectus, as of Dec 31, 2024

Full MEDAX performance history →

What MEDAX costs

On a $10,000 investment, MEDAX's 1.07% expense ratio costs about $107 a year. The prospectus estimates $1,685 in total costs over 10 years (assuming 5% annual returns). The median emerging-markets bond fund charges 0.92%.

See the full MEDAX fee table →

MEDAX top 10 holdings

#Holding% of fund
1MFS Institutional Money Market Portfolio4.42%
2Argentina Republic Government International Bonds1.35%
3Argentina Republic Government International Bonds1.08%
4Ecuador Government International Bonds0.96%
5Argentina Republic Government International Bonds0.95%
6Dominican Republic0.89%
7Colombia Government International Bonds0.82%
8Dominican Republic0.73%
9Paraguay Government International Bonds0.70%
10Ecuador Government International Bonds0.69%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 12.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to MEDAX

More funds like MEDAX →

MEDAX FAQ

What is the expense ratio of MEDAX?
MEDAX's expense ratio is 1.07%, which works out to about $107 a year for every $10,000 invested. The prospectus estimates total costs of $1,685 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MEDAX a good investment?
It depends on your goals, but the data points to: broadly diversified (504 holdings); 5-year return in the bottom quarter of its category; front-end sales load up to 4.25%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does MEDAX hold?
MEDAX's largest holdings are MFS Institutional Money Market Portfolio (4.4%), Argentina Republic Government International Bonds (1.3%), Argentina Republic Government International Bonds (1.1%), Ecuador Government International Bonds (1.0%), Argentina Republic Government International Bonds (1.0%). It holds 504 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is MEDAX's 5-year return?
MEDAX returned +0.1% a year over the five years ending Dec 31, 2024, and +2.5% a year over ten years. Past performance does not guarantee future results.
Does MEDAX have a sales load?
Yes. MEDAX has a maximum front-end sales charge of 4.25%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages MEDAX?
MEDAX is offered by MFS through Mfs Series Trust X.